DEPTOR has been found to be overexpressed in many tumor types, including breast cancer, prostate cancer, chronic myeloid leukemia, lung cancer, and MM [16]. Here, DEPTOR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.